Corrigendum to “Activation of Melanocortin Receptors MC₁ and MC₅ Attenuates Retinal Damage in Experimental Diabetic Retinopathy”

In the article titled “Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy” [1], an error was identified in Figure 3 as raised on PubPeer [2]. Figure 3, BMS-470539 8 weeks, is the same as Figure 3, BMS-470539 16 weeks. The authors explained that this was due to a mistake during manuscript preparation and the corrected figure, as approved by the editorial board, is shown below.

Figure 1.

Representative pictures of FAG showed a regular course and caliber of retinal vessels without microvascular changes or vessel leakage at every time point following intravitreal injection of the MC1 melanocortin receptor agonist BMS-470539 and of the MC5 agonist PG-901. The number of mice for each group was n = 10 nondiabetic mice (baseline) and 8 diabetic mice with retinopathy.